UBS ASSET MANAGEMENT AMERICAS INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,693,224
+7.3%
157,864
+15.2%
0.01%0.0%
Q2 2023$24,880,6850.0%136,9780.0%0.01%0.0%
Q1 2023$24,880,685
+16.4%
136,978
+25.9%
0.01%
+9.1%
Q4 2022$21,381,560
-99.9%
108,812
+3.1%
0.01%
-15.4%
Q3 2022$23,742,035,000
+13.9%
105,553
-35.9%
0.01%
+18.2%
Q2 2022$20,837,336,000
-32.4%
164,709
-32.3%
0.01%
-15.4%
Q1 2022$30,838,626,000
-2.1%
243,226
+1.2%
0.01%
+8.3%
Q4 2021$31,498,033,000
+18.9%
240,443
+11.0%
0.01%
+9.1%
Q3 2021$26,492,153,000
+1.1%
216,563
-5.8%
0.01%0.0%
Q2 2021$26,203,679,000
-5.4%
229,877
-0.2%
0.01%
-8.3%
Q1 2021$27,702,796,000
+9.8%
230,415
-7.2%
0.01%0.0%
Q4 2020$25,237,496,000
+45.2%
248,425
+10.5%
0.01%
+33.3%
Q3 2020$17,378,984,000
-30.7%
224,767
-0.1%
0.01%
-40.0%
Q2 2020$25,078,612,000
+118.5%
225,001
+41.1%
0.02%
+87.5%
Q1 2020$11,478,456,000159,4230.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders